<DOC>
	<DOCNO>NCT02224404</DOCNO>
	<brief_summary>The primary objective post market clinical follow-up ( PMCF ) investigation evaluate performance safety Exufiber use intend Stage II-IV pressure ulcer ( PU ) .</brief_summary>
	<brief_title>Post Market Clinical Follow-up Investigation Evaluate Performance Safety Pressure Ulcers , PU , When Using Exufiber Intended</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>1 . Both gender â‰¥18 year old . 2 . Subjects Stage 2 , 3 4 cavity pressure ulcer ( acc EPUAP ) 3 . Exuding pressure ulcer 4 . Signed Informed Consent . 1 . Known allergy/hypersensitivity dress . 2 . Infected wound , ( 2 sign infection/local inflammation positive swab ) 3 . Stage 1 PU 4 . Dry wound 5 . Subjects problem follow protocol 6 . Subjects include ongoing clinical investigation present past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>